Breaking News, Financial News

4Q Financial Reports: Covance

Covance

4Q Revenues: $343 million (+21%)

4Q Earnings: $30 million (+9%)

FY Revenues: $1.3 billion (+18%)

FY Earnings: $119.6 million (+22%)

Comments: Early development revenues for the quarter grew 24% to $151 million. Full-year revenues grew 17.4% to $562.2 million. Late-stage development revenues for the quarter were $171.4 million, up 16.4% and revenue growth for the year was 16.4% to $631 million. During the year, the company’s backlog increased $210 million, or 14.4%, to a record $1.67 billion.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters